Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2005
10/13/2005US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
10/13/2005US20050227280 Proteases
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227233 Method for diagnosing and treating schizophrenia
10/13/2005US20050226946 Composition obtained from barley shochu stillage and having effects of inhibiting the onset of alcoholic liver injury and healing it as well as favorable taste, and processing for producing the same
10/13/2005US20050226926 Sustained-release tablet composition of pramipexole
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226871 Using mixture of fk-506 and geldanamycin compound immobilized onto polypeptide; both compounds bind to polypeptide components of steroid receptor complexes, hsp90 and FKBP52, respectively
10/13/2005US20050226852 Method of inducing growth of nerve stem cells
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005CA2563038A1 Neurologically-active compounds
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2562123A1 Thiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2562039A1 Heterocyclic cgrp antagonists for the treatment of migraine
10/13/2005CA2561883A1 Treatment of impaired respiratory function with gaboxadol
10/13/2005CA2561732A1 Antibody drug
10/13/2005CA2560684A1 Substituted 1,4,8-triazaspiro[4.5]decan-2-one compounds
10/13/2005CA2560618A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005CA2559136A1 Methods for modulating glutamate receptors for treating neuropsychiatric disorders comprising the use of modulators of serum and glucocorticoid inducible kinases
10/13/2005CA2557719A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005CA2552542A1 Controlled release pharmaceutical composition of tolperisone for oral administration
10/13/2005CA2499113A1 Medicinal product
10/12/2005EP1584925A1 Novel screening method
10/12/2005EP1584333A2 Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
10/12/2005EP1583765A2 Compositions for treating and/or preventing diseases characterized by the presence of metal ions
10/12/2005EP1583758A1 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof
10/12/2005EP1583750A2 MACROCYCLIC BETA-SECRETASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
10/12/2005EP1583748A1 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583562A2 Aprotinin and analogs as carriers across the blood-brain barrier
10/12/2005EP1583553A2 Therapeutic use of modulators of notch
10/12/2005EP1583541A2 Compounds and methods for increasing neurogenesis
10/12/2005EP1583538A1 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases
10/12/2005EP1583531A1 Heteroaryl- substituted pyrrolo' 2, 3- b! pyridine derivatives as crf receptor antagonists
10/12/2005EP1583530A1 2-aminothiazole allosteric enhancers of a1-adenosine receptors
10/12/2005EP1583529A2 Amino acid phenoxy ethers
10/12/2005EP1583525A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1482939A4 Preparation of paroxetine involving novel intermediates
10/12/2005EP1448196B1 Benzothiazole derivatives as adenosine receptor ligands
10/12/2005EP1414819B1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
10/12/2005EP1370568B1 Chemical compounds
10/12/2005EP1335747A4 A composition of sodium channel blocking compound
10/12/2005EP1313485B1 Use of an aldosterone receptor antagonist to improve cognitive function
10/12/2005EP1313467B1 Novel pharmaceutical composition for administering n-0923
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1216047B1 Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005EP1194421B1 Selective npy (y5) antagonists
10/12/2005EP1185293B1 Il6ril6 chimera for the treatment of neurodegenerative diseases
10/12/2005EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1105104B1 Extended release buccal bioadhesive tablet
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005EP1001772B1 Improved delivery of multiple doses of medications
10/12/2005EP0946170B1 Diclofenac for the treatment of vasculopathies
10/12/2005EP0814842B1 Method for treating amyloidosis
10/12/2005EP0760240B1 Composition for stimulating the cerebral activity comprising vinpocetine citrate and a plant extract comprising xanthines
10/12/2005CN1681941A Methods for the treatment of dementia based on APOE genotype
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681822A Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/12/2005CN1681821A Antidepressivt virkende cykloalkylaminderivater AV heterocykle-kondenserte benzodioksaner
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681807A Antidepressant cycloalkylamine derivatives of 2, 3-dihydro-1, 4-benzodioxan
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681803A Aroyl-piperidine derivatives
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681791A 8－羟基喹啉衍生物 8-hydroxyquinoline derivative
10/12/2005CN1681782A 2, 7-substituted indoles and their use as 5-HT6 modulators
10/12/2005CN1681779A 4-pyrrolidino-phenyl-benzyl ether derivatives
10/12/2005CN1681778A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681777A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
10/12/2005CN1681512A Treatment of basal ganglia-related movement disorders with 2, 3-benzodiazepines
10/12/2005CN1681509A Slow release preparation containing larmotriazine
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681499A Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/12/2005CN1681491A Treatment of dyskinesia
10/12/2005CN1681486A Pharmaceutical formulations of modafinil
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680376A Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5- alpha ]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/12/2005CN1680374A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680373A Double piperazine quaternary ammonium salt compound with analgetic function
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680365A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680353A Rice bean flavone extracts and their use
1 ... 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 ... 1833